The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Inspire reported Q2 earnings on August 4, 2025, lowering its full-year revenue guidance and disclosing delays in the rollout of its “Inspire V” system. The Company revealed that treatment centers had postponed the adoption of its new system due to not being able to bill Medicare until July 1, 2025. Based on this news, shares of Inspire fell by almost 40.6% in intraday trading on August 5, 2025.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250805752274/en/